Genetics & Its medicine’s

 

What is Genetics?

A disease caused by abnormalities in individual genome. Some examples are cystic fibrosis, Falcille anemia, Marfan syndrome, Huntington and Hemochromatosis. Unique genetic disorders are genetically informed in recognizable models: Autosomal dominates, automatically diving and xlinked.



There are three types of genetic disorders:

• Distributed disturbances, where mutations affect genes. An example is sickle cell disease.

• Chromosomal disorders, in which chromosomes (or parts of chromosomes) are missing or changed. ...

• Complex disorders in which there are mutations in two or more genes.

Genetic Drugs

 
 Cystagon (Cysteamine Bitartrate)

 

Cysteamine that breaks down cystine in the body. It is used to treat kidney cysts in children and adults. This medicine is used to help maintain kidney function and control kidney damage and other problems in people who have an inherited condition that causes a certain natural substance (cystine) to build up in the body (cystine) renal cyst).

(Form & Strength): 50mg, 150mg

 

Cerdelga (Eliglustat)

 

Cerdelga is a prescription drug used for the long-term treatment of adult Gaucher's disease type 1 (GD1). The ultrafast metabolites of CYP2D6 may not be able to achieve sufficient concentrations of Serderga to produce a therapeutic effect. No specific dose is recommended for undetermined CYP2D6 metabolites.

(Form and strength): 84 mg orally once daily.

 

 

Zavesca

 

Zavesca is used to treat mild to moderate type 1 Gaucher's disease in patients who do not receive enzyme replacement therapy. Zavesca is indicated for oral treatment of adult patients with mild to moderate type 1 Gaucher's disease.

 Zavesca should only be used to treat patients who are not suitable for enzyme replacement therapy.

(Form and Strength): Capsule 100mg

 

 

Elaprase (Idursulfase)

 

Elaprase is a prescription drug for patients with Hunter's syndrome. Elaprase has been shown to improve walking ability in patients over 5 years of age. Idursulfase contains natural enzymes that are deficient due to hereditary disorders. Eraplase helps replace this deficient enzyme. (Form and Strength): Inject 6 mg / 3 ml (2 mg / ml) into a disposable vial.

 

 

Carbaglu

 

Carbaglu is a drug containing the active ingredient carglumic acid. It can be used as a dispersible tablet. "Dispersity" means that tablets can be dispersed (mixed) in water.

Carbaglu is used to treat hyperammonemia (high levels of ammonia in the blood) in patients with the following metabolic disorders: N-acetylglutamate synthase (NAGS) deficiency. Patients with this lifelong condition usually lack a liver enzyme called NAGS that helps break down ammonia.

If the enzyme is deficient, ammonia cannot be broken down and accumulates in the blood. Some organic acidemia (isovaleric acidemia, methylmalonic acidemia, and propionic acidemia) in which the patient lacks certain enzymes involved in protein metabolism.

(Form and strength): 200mg tablet

 

                                            

Normosang (Human-Hemin)

 

Normosang helps to treat sudden attacks that occur in patients suffering from acute liver porphyria. This disease is characterized by liver collection of compounds (including porphyrin and its toxic precursors).

There are three types of liver porphila.

Acute intermittent porphyria,

• Porphyria variegata,

• Hereditary Coropropolia.

This accumulation results in the symptoms of the disease, including pain (mainly belly, backrest, thighs), nausea, vomiting and constipation.

 (Form and Strength): Normosang Injection 250MG

 

 Alleviare Life Science pvt.ltd. A pharmaceutical consulting firm specializing in the delivery of medicines under the Named Patient Program./Manage Access Program. The company caters to the needs of the domestic and international markets. We are one of the leading drug distributors, traders and exporters of anti-cancer drugs, anti-HIV, hepatitis, and specialty life-saving medicines.

 

Comments

Post a Comment

Popular posts from this blog

What Is IDHIFA (Enasidenib)? Causes, Side Effects, Dosage

Image
  WHAT IS IDHIFA (Enasidenib)? IDHIFA Medicine IDHIFA is a prescription medicine used to treat people with acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation whose disease has come back or has not improved after previous treatment(s). It is not known if IDHIFA is safe and effective in children. IDHIFA may cause serious side effects, including: Differentiation Syndrome. Differentiation syndrome is a condition that affects your blood cells which may be life-threatening or lead to death if not treated. Differentiation syndrome has happened within 1 day and up to 5 months after starting IDHIFA. Check the following symptoms below. ·          fever ·          cough ·          shortness of breath ·          swelling of arms and legs ·          fast weight gain (greater than 10 pounds within a week) ·          bone pain If you develop any of these symptoms of differentiation syndrome, your healthcare provider may start you on a medicine taken by m
Read more

Hunter Syndrome is Very Rare | Named Patient Program in India

Image
  Hunter Syndrome is an extremely uncommon, acquired hereditary problem brought about by an absent or breaking down compound. In Hunter disorder, the body needs more of the compound iduronate 2-sulfatase. This present compound's responsibility is to separate specific complex particles, and without enough of this protein, the atoms develop in unsafe sums.  The development of enormous measures of these unsafe substances in the long run causes long-lasting, moderate harm influencing appearance, mental turn of events, organ work and actual capacities. Hunter Syndrome is undeniably more normal in young men. The condition is one kind of a gathering of acquired metabolic issues called mucopolysaccharidoses (MPSs). Tracker condition is otherwise called MPS II. Import Elaprase (idursulfase) medicine under named patient program which is commonly use for hunter syndrome.  There's no remedy for Hunter disorder. Treatment includes overseeing side effects and difficulties. Side effects Syndr
Read more

Glyxambi (empagliflozin and linagliptin) Medicine - Uses, Precautions, Indications

Image
What is Glyxambi? Glyxambi (empagliflozin and linagliptin) is a combination of an inhibitor of the sodium-glucose co-transporter (SGLT2) and an inhibitor of the dipeptidyl peptidase-4 (DPP-4) enzyme as an adjunct to diet and exercise to improve glycemic control. What are the side effects of Glyxambi? Common side effects of Glyxambi include: • urinary tract infection • Common cold symptoms • Upper respiratory tract infection • Genital Yeast Infection • Increased urination • Joint pain • Nausea • runny or stuffy nose • Diarrhea • cough • Elevated blood cholesterol or fat • Diarrhea Glyxambi Dosage The recommended dose of Glyxambi is 10 mg empagliflozin/5 mg linagliptin, taken once daily in the morning, with or without food. In patients who tolerate Glyxambi, the dose may be increased to 25 mg empagliflozin/5 mg linagliptin once daily. Do drugs, substances, or supplements interact with Glyxambi? Glyxambi during pregnancy and lactation During pregnancy
Read more